Changes in Host Immune-Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment Outcomes.
Abstract
A bidirectional communication between the immune and endocrine systems exists and facilitates optimum responses in the host during infections. This is in part achieved through changes in secretion patterns of hypothalamic hormones induced by inflammatory cytokines. The aim of this study was to elucidate the immune-endocrine alterations during tuberculosis (TB) treatment in patients with cured and failed TB treatment outcomes. Blood samples were collected from 27 cured and 10 failed patients and hormone as well as cytokine concentrations quantified at baseline, week 4, and month 6 of TB treatment. Hormone profiles of the two treatment outcome groups were different from each other prior to as well as during TB treatment. Treatment response effects were observed for cortisol, estradiol, T3, T4 ghrelin, leptin, amylin, adiponectin, and dehydroepiandrosterone (DHEA). Trends suggest that T4, amylin, and DHEA concentrations were different between treatment outcomes, although these did not reach statistical significance. Relationships between endocrine and inflammatory markers and the biological pathways involved differed between cured and failed treatment patients. These results highlight the complex interaction between the endocrine and immune system during active TB disease and throughout treatment and suggest that endocrine markers in conjunction with inflammatory markers may be useful in predicting unfavorable treatment outcomes.
DRG product(s) used in the study above
You can view the product details and buy it now
DHEA
Kleynhans L1, Ruzive S1, Ehlers L1, Thiart L1, Chegou NN1, Conradie M2, Kriel M1, Stanley K1, van der Spuy GD1, Kidd M3, van Helden PD1, Walzl G1, Ronacher K1,4.
Author Information
1. SA MRC Centre for TB Research, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Department of Biomedical Sciences, Stellenbosch University, Cape Town, South Africa.
2. Division of Endocrinology and Metabolism, Faculty of Medicine and Health Sciences, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
3. Centre for Statistical Consultation, Stellenbosch University, Stellenbosch, South Africa.
4. Translational Research Institute, Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.
Front Immunol. 2017 Jun 15;8:690. doi: 10.3389/fimmu.2017.00690. eCollection 2017.
Link: https://www.ncbi.nlm.nih.gov/pubmed/28674532
by Oleg Vishnevski | Jun 15, 2017